<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnmol.2017.00334</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: The Physiological Functions of the APP Gene Family</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>M&#x000FC;ller</surname> <given-names>Ulrike C.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/6441/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Deller</surname> <given-names>Thomas</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1970/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Functional Genomics, Institute for Pharmacy and Molecular Biotechnology, Universit&#x000E4;t Heidelberg</institution>, <addr-line>Heidelberg</addr-line>, <country>Germany</country></aff>
<aff id="aff2"><sup>2</sup><institution>Institute of Clinical Neuroanatomy, Neuroscience Center, Goethe University Frankfurt</institution>, <addr-line>Frankfurt</addr-line>, <country>Germany</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited and reviewed by: Nicola Maggio, Sackler Faculty of Medicine, Tel Aviv University, Israel</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Ulrike C. M&#x000FC;ller <email>u.mueller&#x00040;urz.uni-heidelberg.de</email></p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>10</volume>
<elocation-id>334</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>09</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>10</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 M&#x000FC;ller and Deller.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>M&#x000FC;ller and Deller</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/4738/the-physiological-functions-of-the-app-gene-family" ext-link-type="uri">Editorial on the Research Topic <article-title>The Physiological Functions of the APP Gene Family</article-title></related-article>
<kwd-group>
<kwd>amyloid precursor protein (APP)</kwd>
<kwd>APP like proteins</kwd>
<kwd>synaptic plasticity</kwd>
<kwd>development</kwd>
<kwd>spine density</kwd>
<kwd>neuroprotection and neuronal repair</kwd>
<kwd>synaptogenesis</kwd>
<kwd>secretases</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="2"/>
<page-count count="2"/>
<word-count count="1332"/>
</counts>
</article-meta>
</front>
<body>
<p>The amyloid precursor protein APP plays a key role in the pathogenesis of Alzheimer&#x00027;s disease (AD), as proteolytical cleavage of APP gives rise to the &#x003B2;-amyloid peptide A&#x003B2;, which is deposited in the brains of AD patients (Selkoe and Hardy, <xref ref-type="bibr" rid="B2">2016</xref>). In contrast to this key role in AD, the reviews and original papers in this Special Issue entitled &#x0201C;The physiological functions of the APP gene family&#x0201D; aim to shed some light on the &#x0201C;bright side&#x0201D; of APP, which exhibits important physiological functions during brain development, for adult brain plasticity and protection against injury. This change of perspective is timely, since accumulating evidence suggests that disease symptoms are caused both by an overload of toxic substances, e.g., &#x0201C;too much A&#x003B2;,&#x0201D; as well as deficits of protective molecules, e.g., &#x0201C;not enough APPs&#x003B1;.&#x0201D;</p>
<p>Unraveling APP functions has not been trivial, since APP undergoes complex processing. APP processing is initiated either by &#x003B1;-secretase cleavage within the A&#x003B2; region, or by &#x003B2;-secretase (BACE) cleavage at the N-terminus of A&#x003B2;, leading to the secretion of large soluble ectodomains, termed APPs&#x003B1; and APPs&#x003B2;, respectively. Subsequent processing of the C-terminal fragments (CTF&#x003B1; or CTF&#x003B2;) by &#x003B3;-secretase results in the production of A&#x003B2;, p3 and the APP intracellular domain (AICD). This processing&#x02014;as well as processing along non-canonical pathways (see M&#x000FC;ller et al., <xref ref-type="bibr" rid="B1">2017</xref>, for review) results in numerous fragments, which have different and partially opposite functional properties. Furthermore, APP functions are in part shared by APP-like proteins 1 and 2 (APLP1 and 2), which confounds some experimental approaches. Finally, expression changes over time and with aging add additional levels of complexity. In short, understanding APP gene family functions is challenging and this special issue provides a broad overview of the state-of-the art in this field.</p>
<p>Several reviews (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2016.00149">Seipold and Saftig</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2017.00056">Endres and Deller</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2017.00097">Yan</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2016.00159">Becker-Pauly and Pietrzik</ext-link>) focus on the properties of canonical and non-canonical &#x003B1;-, and &#x003B2;-secretases, their substrates, regulation, and neurobiological functions in health and disease. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2016.00096">M&#x000FC;ller et al.</ext-link> give a systematic overview over proteomic methods to systematically identify the substrates of membrane proteases. The knowledge of these substrates is crucial to identify the physiological and pathological functions of secretases and to assess potential risks of their pharmacological impairment to treat AD (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2017.00056">Endres and Deller</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2017.00097">Yan</ext-link>). In addition, there is evidence that the secretases which are transmembrane proteases can form larger complexes with other cell surface proteins that may modulate their activity including members of the tetraspannin family (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2017.00037">Seipold and Saftig</ext-link>). APP processing is further modulated by the lipid composition of the plasma membrane and accumulating evidence suggests that A&#x003B2; and the AICD play an important role in regulating lipid homeostasis (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2017.00063">Grimm et al.</ext-link>). Likewise, lipoprotein receptors may interact with APP to control developmental processes and synaptic function (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2017.00054">Pohlkamp et al.</ext-link>). They have been shown to not only regulate A&#x003B2; uptake and degradation, but also APP processing and APP trafficking. In this regard, employing live cell imaging in primary neurons <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2017.00118">Herr et al.</ext-link> demonstrate that low-density lipoprotein receptor-related protein 1 (LRP1) modulates the axonal transport of APP monomers and dimers.</p>
<p>There is a large body of evidence indicating that APP family proteins are multimodal proteins that can function as ligands via their secreted fragments, in particular APPs&#x003B1;, or as cell surface proteins mediating signal transduction and synaptic adhesion (as reviewed by M&#x000FC;ller et al., <xref ref-type="bibr" rid="B1">2017</xref>). <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2017.00021">Wild et al.</ext-link> discuss how metal (Cu and Zn) binding affects the structure of the APP extracellular domain and may modulate its role as a synaptic adhesion molecule. As APP family proteins have no enzymatic activities, signal transduction relies on interactions with other membrane proteins and/or adaptors. The role of the Fe65 adaptor family is summarized by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2017.00087">Guenette et al.</ext-link> Fe65 binding to the APP C-terminus involves its phosphotyrosine-binding (PTB) domain 2 which can also mediate the formation of cytosolic Fe65 dimers, as shown by X-ray crystallography (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2017.00140">Feilen et al.</ext-link>). The importance of heteromeric G-protein interactions with the APP C-terminus for physiological APP signaling and AD pathogenesis is reviewed by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2017.00003">Copenhaver and Kogel</ext-link>.</p>
<p>Major insight into the <italic>in vivo</italic> functions of APP family proteins has been obtained from animal models. <italic>Drosophila</italic> expresses only one APP protein called APP-like (APPL) and two reviews (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2016.00061">Cassar and Kretzschmar</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2016.00142">Preat and Goguel</ext-link>) deal with APPL functions in flies. In mice the analysis of APP functions is complicated by partially overlapping functions within the gene family and lethality of double and triple knockout mice (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2017.00189">Han et al.</ext-link>). To circumvent early postnatal lethality mice with conditional floxed alleles have been generated (M&#x000FC;ller et al., <xref ref-type="bibr" rid="B1">2017</xref>). Together, the analysis of engineered mouse models indicated that APP family proteins and their proteolytic fragments are important during nervous system development for neuronal migration, neurite outgrowth, axonal pathfinding, and synaptogenesis (M&#x000FC;ller et al., <xref ref-type="bibr" rid="B1">2017</xref>). Proteomic studies, reviewed by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2017.00043">Weingarten et al.</ext-link> established APP family proteins as important components of the active zone. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2017.00221">Lazarevic et al.</ext-link> demonstrated that low amounts of A&#x003B2; are involved in the regulation of neurotransmitter release. It should be noted, however, that APP family proteins have also been localized at postsynaptic sites including the neuromuscular junction. In addition, APP family proteins have important functions in the adult hippocampus, where they are differentially expressed in all subregions (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2016.00134">Del Turco et al.</ext-link>) and regulate synaptic plasticity and memory (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2016.00161">Ludewig and Korte</ext-link>). The recently identified function of APP for structural spine plasticity is summarized by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2017.00136">Montagna et al</ext-link>. In particular APPs&#x003B1; holds great therapeutic potential for AD as reviewed by Mockett et al. Finally, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2017.00022">Hefter and Draguhn</ext-link> highlight the role of APP and APPs&#x003B1; as a protective factor for acute neuronal insults including hypoxia.</p>
<p>We thank all contributors for their interesting and informative articles and the reviewers for their constructive and thoughtful suggestions.</p>
<sec id="s1">
<title>Author contributions</title>
<p>UM and TD wrote the manuscript and both authors approved the final version for publication.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>M&#x000FC;ller</surname> <given-names>U. C.</given-names></name> <name><surname>Deller</surname> <given-names>T.</given-names></name> <name><surname>Korte</surname> <given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Not just amyloid: physiological functions of the amyloid precursor protein family</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>18</volume>, <fpage>281</fpage>&#x02013;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1038/nrn.2017.29</pub-id><pub-id pub-id-type="pmid">28360418</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Selkoe</surname> <given-names>D. J.</given-names></name> <name><surname>Hardy</surname> <given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>The amyloid hypothesis of Alzheimer&#x00027;s disease at 25 years</article-title>. <source>EMBO Mol. Med.</source> <volume>8</volume>, <fpage>595</fpage>&#x02013;<lpage>608</lpage>. <pub-id pub-id-type="doi">10.15252/emmm.201606210</pub-id><pub-id pub-id-type="pmid">27025652</pub-id></citation></ref>
</ref-list>
<fn-group>
<fn fn-type="financial-disclosure"><p><bold>Funding.</bold> The authors thank the Deutsche Forschungsgemeinschaft for their support within programme FOR1332.</p>
</fn>
</fn-group>
</back>
</article>
